Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
Clinical trial NCT02346240 · COMPLETED
Trial details
- NCT number
- NCT02346240
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-11
- Primary completion
- 2016-03-22
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.